The beta subunit common to the GM-CSF, IL-3 and IL-5 receptors is highly polymorphic but pathogenic point mutations in patients with acute myeloid leukaemia (AML) are rare

Leukemia

Volumn 10, Issue 1, 1996, Pages 123-129

  Freeburn, R W ^a   Gale, R E ^a   Wagner, H M ^a   Linch, D C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AML; Beta chain; Cytokine receptor; Polymorphism

Indexed keywords

GLYCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR RECEPTOR; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 5 RECEPTOR; METHIONINE; PROLINE; RNA; THREONINE; VALINE;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0030054322     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989; 339: 27-31.
2. Miyajima A, Mui A, Ogorochi T, Sakamaki K. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5. Blood 1993; 82: 1960-1974.
3. Hayashida K et al. Molecular cloning of a second subunit of the receptor for the human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 1990; 87: 9655-9659.
4. Bazan J. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990; 87: 6934-6938.
5. Sakamaki K, Miyajima I, Kitamura T, Miyajima A. Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 1992; 11: 3541-3549.
6. Sato N et al. Signal transduction by the high affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signalling EMBO J 1993; 12: 4181-4189.
7. Russell NH. Autocrine growth factors and leukaemic haemopoiesis. Blood Rev 1992; 6: 149-156.
8. Lowenberg B, Touw IP. Haematopoietic growth factors and their receptors in acute leukaemia. Blood 1993; 81: 281-292.
9. Farr C et al. Analysis of Ras gene mutations in acute myeloid leukaemia by polymerase chain reaction and oligonucleotide probes. Proc Natl Acad Sci USA 1988; 85: 1629-1633.
10. Toksoz D, Farr C, Marshall C. Ras genes and acute myeloid leukaemia. Br J Haematol 1989; 71: 1-6.
11. Yoshimura A, Longmore C, Lodish HF. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 1990, 348: 647-649.
12. Kitayama H et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995; 85: 790-798.
13. D'Andrea R et al. A mutation of the common receptor subunit for the interleukin-3 (IL-3), granalocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity. Blood 1994; 83: 2802-2808.
14. Wetters T, Hawkins S, Roussel M, Sherr C. Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain. EMBO J 1992; 11: 551-557.
15. Tobal K et al. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukaemia Leukemia 1990; 4: 486-489.
16. Ridge S et al. FMS mutations in myelodysplastic, leukemic and normal subjects. Proc Natl Acad Sci USA 1990; 87: 1377-1380
17. De La Chapelle A, Traskelin A, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign erythrocytosis. Proc Natl Acad Sci USA 1993; 90: 4495-4499.
18. Touw I et al. Point mutations in the G-CSF-R gene in severe congenital neutropenia terminating in acute myeloid leukaemia. Blood 1994; 84 (suppl. 1) 375.
19. Dong F et al. A point mutation in the granulocyte colony-stimulating factor receptor (G-CSF-R) gene in a case of acute myeloid leukaemia results in the over-expression of a novel G-CSF-R isoform. Blood 1995; 85: 902-911.
20. Cannistra S et al. Differentiation-associated expression of two functionally distinct classes of granulocyte-macrophage colony-stimulating factor receptors by human myeloid cells. J Biol Chem 1990; 265: 12656-12663.
21. Wagner HM et al. Analysis of mutations in the GM-CSF receptor α coding sequence in patients with acute myeloid leukaemia and haematologically normal individuals by RT-PCR-SSCP. Leukemia 1994; 8: 1527-1532.
22. Takai S et al. Mapping of the human gene encoding the mutual signal-transducing subunit (β-chain) of granulocyte-rnacrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and interleukin-5 (IL-5) receptor complexes to chromosome 22q13.1 Hum Genet 1994; 93: 198-200.
23. Kitamura T, Sato N, Arai K, Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66: 1165-1174.
24. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning: A Laboratory Manual ((2nd edn). Cold Spring Harbor Press: Cold Spring Harbor, NY, 1989, (7.19-7.22).
25. Hayashi K. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Meth Appl 1991; 1 34-38.
26. Keohavong P, Thilly W. Fidelity of DNA polymerases in DNA amplification. Proc Natl Acad Sci USA 1989; 86: 9253-9257.
27. Brown M et al. Structure and expression of the GM-CSF receptor α and β chain genes in human leukaemia. Leukemia 1993; 7: 63-74.
28. Sarkar G, Yoon H, Sommer S Screening for mutations by RNA single-strand conformation polymorphism ((rSSCP): comparison with DNA-SSCP. Nucleic Acids Res 1992; 20: 871-878.
29. Glavac M, Glavac D, Dean M. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Genet 1994; 3 801-807.
30. Hess G et al. Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera. Br J Haematol 1994; 88: 794-802.
31. Bernard T, Gale R, Linch D. RT-PCR SSCP analysis of the granulocyte colony-stimulating factor receptor in acute myeloid leukaemia. Br J Haematol 1995; 89 (suppl. 1): 40.
32. Carapeti M, Goldman J, Cross N. Mutations in the cytoplasmic domain of the G-CSF receptor are found infrequently in patients with acute myeloid leukaemia. Br J Haematol 1995; 89 (suppl. 1): 63.
33. Sandoval C et al. The cytoplasmic portion of the G-CSF receptor is normal in patients with Kostmann syndrome. Blood 1993; 82 (suppl 1): 185.
34. Guba S et al. Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood 1994; 83: 1486-1492.
35. Bird A. The essentials of DNA methylation. Cell 1992, 70: 5-8.
36. Cooper D, Krawczak M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet 1989; 83: 181-188.
37. Sanson M et al. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 1993; 2: 1215-1220.
38. Sutherland G et al. The gene for human leukaemia inhibitory factor (LIF) maps to 22q12. Leukemia 1989; 3: 9-13.